CML (chronic myelogenous leukemia) is a disease with a myeloproliferative disorder in hematopoietic stem cells, and its character shows the expression of the BCR-ABL fusion oncoprotein and the Philadelphia chromosome [1]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.